Artemis Medicare Services Limited announced its Q4 and FY2025 consolidated financial results.
For FY25, Gross Revenue stood at INR 9,819 Mn, up 6.5% YoY from INR 9,222 Mn in FY24.
Net Revenue from Operations for FY25 was INR 9,369 Mn, a 6.6% increase from INR 8,786 Mn in FY24.
EBITDA for FY25 grew significantly by 31.9% to INR 1,848 Mn compared to INR 1,401 Mn in FY24.
Profit After Tax (PAT) for FY25 saw a substantial rise of 67.2% to INR 822 Mn from INR 491 Mn in FY24.
For Q4 FY25, Gross Revenue was INR 2,521 Mn (up 7.0% YoY), Net Revenue was INR 2,399 Mn (up 6.5% YoY), EBITDA was INR 482 Mn (up 21.1% YoY), and PAT was INR 229 Mn (up 60.3% YoY).
Operational performance at Artemis Hospital, Gurgaon for FY25 included Average Operational Census Beds of 489, Occupancy of 64.1%, ARPOB of INR 80,200, Patient Volumes of 381,968, and ALOS of 3.6 days.
Mr. Onkar Kanwar, Chairman, stated, "Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve."
He also mentioned the inauguration of the third tower at the Gurgaon facility, which will be commissioned phase-wise to accommodate increasing demand.
The company raised ₹330 Crore from International Finance Corporation (IFC) to fuel expansion across Delhi NCR and select Tier 2 cities through brownfield and greenfield projects.
The Board approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur, marking expansion into Central India.
Strategic growth vision includes opening the third tower at Gurgaon taking capacity to 700+ beds, expanding in the super-speciality segment, focusing on the asset-light model, and increasing international footprint.